CDK4/6 inhibitors target the CDK4/6 complex, thereby promoting the activation of retinoblastoma protein, which hinders cancer cells from entering the G1 checkpoint to the S phase of the cell cycle.65 The gene discussed is CDK4; the disease is cancer.